MCQOPTIONS
Saved Bookmarks
| 1. |
Which of the following has launched antiviral drug Favipiravir, under the brand name FabiFlu, for the treatment of patients with mild to moderate COVID-19? |
| A. | Glenmark Pharmaceuticals |
| B. | Cadila Healthcare |
| C. | Sun Pharma |
| D. | Cipla |
| E. | Lupin Limited |
| Answer» B. Cadila Healthcare | |